Depression and Anxiety in Patients with Respiratory Diseases

Matsuda Yoshinobu

doi:10.15064/jjpm.63.6_520

<p>Patients with respiratory diseases frequently experience depression and anxiety. However, a pharmacotherapy for depression and anxiety in patients with respiratory diseases has not yet been established. Additionally, the use of high-dose benzodiazepines in patients with chronic obstructive pulmonary disease (COPD) has been associated with mortality. Therefore, nonpharmacological therapies are preferred. In particular, respiratory rehabilitation, the standard treatment for COPD, has been shown to be effective for depression. In addition, cognitive behavioral therapy has been reported to reduce psychological distress in patients with COPD. In daily clinical practice, a multidisciplinary approach in collaboration with rehabilitation departments, nurses, and psychologists can improve the vicious cycle of cognitive models of patients with COPD. Thus, the role of psychologists in the palliative care of patients with respiratory diseases is expected to increase. A questionnaire survey conducted among respiratory physicians revealed that respiratory physicians expect psychologists to “alleviate psychological distress by getting information about distress experienced by patients and their families early and providing psychological support.”</p>

Depression and Anxiety in Patients with Respiratory Diseases

Bibliographic Information

Abstract

Journal

Keywords

Details 詳細情報について

Export

Report a problem